π Pharmidex is thrilled to announce our participation in the GMP Symposium 2024 in Lyon!
October 11, 2024
We’re excited to connect and engage with industry professionals at this important event, sharing insights on pharmaceutical innovation and best practices in Good Manufacturing Practices (GMP).
π
Event Date: October 16-18, 2024
π Location: Lyon, France
π Find Us at Booth #2!
Our Head of Business Development,
Martin Barrett, will be at Booth #2 showcasing our range of services. Don’t hesitate to stop by, meet him, and explore how
Pharmidex can support your projects with our cutting-edge expertise in drug discovery and development.
Let’s create impactful collaborations and drive the future of healthcare together! πβ¨

#Pharmidex #GMPSymposium2024 #PharmaceuticalInnovation #Booth2 #Lyon2024 #BusinessDevelopment #HealthcareCollaboration

πβοΈβοΈ Congratulations to our Pharmidex team members who took part in the St Albans Summer Solstice 10K #BeatTheSunset ! It was great to see colleagues enjoying a fantastic summer evening while supporting their physical and mental wellbeing. At Pharmidex , we believe health extends beyond the laboratory and activities like these are a great way to stay active, connect with colleagues and have fun. Well done to everyone who took part and represented Pharmidex so positively!

A big thank you to our interns from City St George’s, University of London and heir fantastic contribution to Pharmidex over the past few months. They have supported scientific projects across the business, developed valuable technical skills and gained hands-on experience within a CRO environment. Their contribution has extended beyond the laboratory, helping with our website, marketing materials, conference preparation and business development activities. Science drives success, but communicating that science effectively is just as important. Our interns have helped us do both. Thank you for your hard work, enthusiasm, and dedication. We wish you every success in the next stage of your careers.

On 18 June, our COO, Ash Alavijeh , will join an industry panel discussing: "What are the advantages and disadvantages of working with UK-based Discovery CROs?" The session will explore the value of UK CROs in supporting innovation, protecting IP, accessing scientific expertise and accelerating drug discovery programmes. π
18 June 2025 π Cambridge π Panel Session: 12:20–12:45 We look forward to connecting with colleagues, collaborators, and innovators from across the life sciences community.




